When does PREDICTIVE ONCOLOGY INC (POAI) report earnings?
PREDICTIVE ONCOLOGY INC (POAI) will report earnings on 2026-03-30.
PREDICTIVE ONCOLOGY INC (POAI) Forecast, Price Target & Analyst Ratings
NASDAQ:POAI • US74039M4087
Current stock price
5.95 USD
+0.03 (+0.51%)
At close:
5.8945 USD
-0.06 (-0.93%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for PREDICTIVE ONCOLOGY INC (POAI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.06
- Revenue Estimate
- 5.1M
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $5.95 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
POAI was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about POAI.
In the previous month the buy percentage consensus was at a similar level.
POAI was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-11-15 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-08-19 | HC Wainwright & Co. | Initiate | Buy |
| 2021-06-30 | HC Wainwright & Co. | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 30, 2026
- Period
- Q4 / 2025
- EPS Estimate
- $0.06
- Revenue Estimate
- 5.1M
- Revenue Q2Q
- 733.33%
- EPS Q2Q
- 101.70%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
POAI is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is 0.06 USD and the consensus revenue estimate is 5.10M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2025 - 2027
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.51M 6.34% | 1.628M 7.79% | 1.624M -0.24% | 9.52M 486.28% | 15.756M 65.50% | 24.448M 55.17% | |
| EBITDA YoY % growth | -13.95M -15.00% | -11.71M 16.06% | -10.777M 7.96% | N/A | N/A | N/A | |
| EBIT YoY % growth | -15.26M -13.29% | -11.955M 21.66% | -10.94M 8.49% | -1.895M 82.68% | 1.58M 183.37% | 6.983M 341.96% | |
| Operating Margin | -1,010.60% | -734.46% | -673.70% | -19.91% | 10.03% | 28.56% | |
| EPS YoY % growth | N/A 99.72% | N/A 61.29% | N/A -25,900.00% | -0.13 99.58% | 0.08 161.54% | 0.28 237.50% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | 0.06 101.70% |
| Revenue Q2Q % growth | 5.1M 733.33% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
26.17%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
158.10%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
PREDICTIVE ONCOLOGY INC / POAI Forecast FAQ
What are the consensus estimates for POAI stock next earnings?
The consensus EPS estimate for the next earnings of PREDICTIVE ONCOLOGY INC (POAI) is 0.06 USD and the consensus revenue estimate is 5.10M USD.
What is the expected long term growth rate for PREDICTIVE ONCOLOGY INC (POAI)?
The expected long term growth rate for PREDICTIVE ONCOLOGY INC (POAI) is 158.1%.